Lv41
476 积分 2025-11-12 加入
CT Radiomics–based Machine Learning to Identify Intratumoral Fibrosis and Underlying Angiogenesis in Hepatocellular Carcinoma
10天前
已完结
Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma
10天前
已完结
Noninvasive Tumor Profiling: Quantitative Contrast-enhanced MRI Markers Help Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma
20天前
已完结
Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma
20天前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
2个月前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
3个月前
已完结
The Harvard-Emory ECG Database
3个月前
已关闭
“Biological R2” resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection
4个月前
已关闭
Nomogram for prediction of severe postoperative complications in elective hepato-pancreato-biliary surgery after COVID-19 breakthrough infection: A large multicenter study
4个月前
已关闭
Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
